Health COVID-19: anticoagulants to help patients? | COVID-19...

COVID-19: anticoagulants to help patients? | COVID-19 | News | The sun


En based on the analysis of some 3,000 patients admitted since mid-March, the researchers found that the average survival time of patients fell from 14 days to 21 days with the addition of anticoagulants, according to the Medscape website .

The effect was particularly marked in the sickest patients who needed artificial help to breathe: the death rate plunged from 62.7% to 29.1% with anticoagulant therapy. The average survival time decreased from nine days to 21 days.

An official at Mount Sinai said that all admitted SARS-CoV-2 patients will now receive anticoagulants, unless medically contraindicated.

COVID-19 seems to promote the formation of clots, but the exact role of anticoagulants in the fight against the disease remains to be clarified.

The study was published by the Journal of the American College of Cardiology.


Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Latest news

Best Buy July 4 Sale Takes $ 100 Off This 55-inch 4K TV With Free Echo Point

The sale on July 4, 2020 is in full swing with fantastic offers from your favorite retailers. If...

Rotterdammers conquer the eve of NPO1

Saturday, July 4, 2020, 7:50 PM From August 31, Fidan Ekiz and Renze Klamer will present a new talk show...

Vettel surprised at Ferrari’s dramatic qualification in Austria | NOW

Sebastian Vettel was astonished on Saturday at...

“Get TikTok off your phone immediately” –

Immediately remove TikTok from your phone. A software specialist on the social network Reddit makes that appeal. ...

Meloni warns Salvini: “Center-right leader who leads the party with more votes”

<!-- --> Meloni: "Leader of the Right Center will be the one who leads the party with the...

Must read

You might also likeRELATED
Recommended to you